Exploring stakeholder perceptions of facilitators and barriers to accessing methadone maintenance clinics in Yunnan Province, China

AIDS Care - Psychological and Socio-Medical Aspects of AIDS/HIV

Volumn 22, Issue 5, 2010, Pages 623-629

  Philbin, Morgan M ^a   Zhang, Fujie ^b  

^a JOHNS HOPKINS BLOOMBERG SCHOOL OF PUBLIC HEALTH   (United States)

^b CHINESE CENTER FOR DISEASE CONTROL AND PREVENTION   (China)

Author keywords

China; Harm reduction; HIV AIDS; Methadone maintenance treatment

Indexed keywords

METHADONE;

ACQUIRED IMMUNE DEFICIENCY SYNDROME; ADULT; ARTICLE; AWARENESS; BACKACHE; BEHAVIOR THERAPY; CHINA; CLINICAL ARTICLE; CLINICAL EVALUATION; CONTENT ANALYSIS; CONTROLLED STUDY; DRUG COST; DRUG DEPENDENCE; DRUG DEPENDENCE TREATMENT; DRUG USE; DRUG UTILIZATION; FEMALE; HARM REDUCTION; HEALTH CARE ACCESS; HEALTH PERSONNEL ATTITUDE; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; INTERVIEW; MAINTENANCE THERAPY; MALE; PATIENT COUNSELING; PRIORITY JOURNAL; PRIVACY; QUALITATIVE RESEARCH; SIDE EFFECT; SOCIAL DISCRIMINATION; SOCIAL PROBLEM; VIRUS TRANSMISSION; WEIGHT REDUCTION;

ACQUIRED IMMUNODEFICIENCY SYNDROME; ADULT; AMBULATORY CARE FACILITIES; CHINA; HARM REDUCTION; HEALTH PERSONNEL; HIV INFECTIONS; HUMANS; METHADONE; NARCOTICS; OPIATE SUBSTITUTION TREATMENT; PATIENT ACCEPTANCE OF HEALTH CARE; QUALITATIVE RESEARCH; SUBSTANCE ABUSE, INTRAVENOUS;

EID: 77952469931     PISSN: 09540121     EISSN: 13600451     Source Type: Journal    
DOI: 10.1080/09540120903311490     Document Type: Article

References (45)

1. Chen, H. (2007). The grim situation of Yunnan Province's HIV/AIDS prevention: Over 30, 000 estimated cumulative AIDS cases. Retrieved September 10, 2008, from www.xinhaunet.com.
2. China Ministry of Health (2001). Ministry of Health: National HIV/AIDS Surveillance Report 1998-2000. Beijing, China: National Center on AIDS and STDs.
3. Chu, T., & Levy, J. (2005). Injection drug use and HIV/AIDS transmission in China. Cell Research, 15, 865.
4. Cooper, H., Moore, L., Gruskin, S., & Krieger, N. (2005). The impact of a police drug crackdown on drug injectors' ability to practice harm reduction: A qualitative study. Social Science and Medicine, 61, 673.
5. Des Jarlais, D., Paone, D., Friedman, S., Peyser, N., & Newman, R. (1995). Regulating controversial programs for unpopular people: Methadone maintenance and syringe exchange programs. American Public Health Association, 85, 1577.
6. Drucker, E., Lurie, P., Wodak, A., & Alcabes, P. (1998). Measuring harm reduction: The effects of needle and syringe exchange programs and methadone maintenance on the ecology of HIV. AIDS, 12 (Suppl. A), S217-S230.
7. Firestone-Cruz, M., Mantsios, A., Ramos, R., Case, P., Brouwer, K., & Ramos, M. (2006). A qualitative exploration of gender in the context of injection drug use in two-US-Mexico border cities. AIDS and Behavior, 11 (2), 253-262.
8. Hagan, H., McGough, J., Thiede, H., Hopkins, S., Duchin, J., & Alexander, E. (2000). Reduced injection frequency and increased entry and retention in drug treatment associated with needle-exchange participation in Seattle drug injector. Journal of Substance Abuse Treatment, 19 (3), 247-252.
9. Hammett, T., Bartlett, N., Chen, Y., Ngu, D., Cuong, D., Phuong, N., et al. (2005a). Law enforcement influences on HIV prevention for injection drug users: Observations from a cross-border project in China and Vietnam. International Journal of Drug Policy, 16 (4), 235-245. (Pubitemid 41558181)
10. Hammett, T., Des Jarlais, D., Liu, W., Ngu, D., Tung, N., Hoang, T., et al. (2003). Development and implementation of a cross-border HIV prevention intervention for injection drug users in Ning Ming County (Guangxi Province), China and Lang Son Province, Vietnam. International Journal of Drug Policy, 14 (5-6), 389-398.
11. Hammett, T., Norton, G., Kling, R., Liu, W., Chen, Y., Ngu, D., et al. (2005b). Community attitudes toward HIV prevention for injection drug users: Finding from a cross-border project in Southern China and Northern Vietnam. Journal of Urban Health, 82 (3 Suppl. 4), iv34-iv44.
12. Hammett, T., Wu, Z., Duc, T., Stephens, D., Sullivan, S., Liu, W., et al. (2007). Social evils' and harm reduction: The evolving policy environment for human immunodeficiency virus prevention among injection drug users in China and Vietnam. Addiction, 103, 137.
13. Henderson, L., Vlahov, D., Celentano, D., & Strathdee, S. (2003). Readiness for cessation of drug use among recent attenders and nonattenders of a needle exchange program. Journal of Acquired Immune Deficiency Syndromes, 32 (2), 229-237.
14. Joseph, H., Stancliff, S., & Langrod, J. (2000). Methadone maintenance treatment: A review of historical and clinical issues. Mt. Sinai Journal of Medicine, 67 (5-6), 347-364.
15. Kitsenko, G., Shakhov, A., Lazzarini, Z., Case, P., Chintalova-Dallas, R., & Burris, S. (2008, May 11-15). Harm reduction training in law schools in Ukraine. Paper presented at the 19th International Harm Reduction Conference, Barcelona, Spain.
16. Kozachenko, N., Darbekova, G., Mingazova, I., Burris, S., Case, P., & Chintalova-Dallas, R. (2008, May 11-15). Evaluation of drug policy and HIV/AIDS prevention programs in Kazakhstan (Temirtau and Shymkent): Summary of RPAR results. Paper presented at the 19th International Harm Reduction Conference, Barcelona, Spain.
17. Lazzarini, Z., Case, P., Burris, S., & Chintalova-Dallas, R. (2007, May 13-17). Three easy policy changes to improve the risk environment for IDUs in Eastern Europe and the Former Soviet Union. Paper presented at the 18th International Harm Reduction Conference, Warsaw, Poland.
18. Lu, L., Zhao, D., Bao, Y., & Shi, J. (2008). Methadone maintenance treatment of heroin abuse in China. The American Journal of Drug and Alcohol Abuse, 34 (2), 127-131.
19. Malcolm, S. (2003). An examination of HIV/AIDS patients who have excellent adherence to HAART. AIDS Care, 15, 251.
20. Muhr, T. (2004). Atlas.ti - The knowledge workbench. Visual qualitative data analysis management model building. Berlin, Germany: Scientific Software Development.
21. National Center for AIDS and STDs (NCAIDS) (2008). Scaling up the methadone maintenance treatment program in China. Retrieved September 15, 2008. http://www.unaids.org.cn/en/index/Document-view.asp?id=295
22. Pang, L., & Hao, Y. (2007). Effectiveness of the first eight methadone maintenance treatment clinics in China. AIDS, 21 (8), S103-S109.
23. Peles, E., Schreiber, S., & Adelson, M. (2006). Factors predicting retention in treatment: 10-year experience of a methadone maintenance treatment (MMT) clinic in Israel. Drug and Alcohol Dependence, 82, 211.
24. Philbin, M., Mantsios, A., Lozada, R., Case, P., Pollini, R., Alvelais, J., et al. (2008). Exploring stakeholder perceptions of acceptability and feasibility of needle exchange programmes, syringe vending machines and safer injection facilities in Tijuana, Mexico. International Journal of Drug Policy, 20 (4), 329-335.
25. Powell-Cope, G., White, J., Henkelman, E., & Turner, B. (2003). Qualitative and quantitative assessments of HAART adherence of substance-abusing women. AIDS Care, 15 (2), 239-249.
26. Powers, R. (1998). The role of qualitative research in HIV/AIDS. AIDS, 12 (7), 687-695.
27. Qian, H., Schumacher, J., Chen, H., & Ruan, Y. (2006). Injection drug use and HIV/AIDS in China: Review of current situation, prevention, and policy implication. Harm Reduction Journal, 3, 4.
28. Reid, G., & Costigan, G. (2002). Revisiting "The hidden epidemic": A situation assessment of drug use in Asia in the context of HIV/AIDS. Melbourne, Australia: Centre for Harm Reduction, Burnet Institute.
29. Rhodes, T., Kimber, J., Small, W., Fitzgerald, J., Kerr, T., & Hickman, M. (2006). Public injecting and the need for safer environment interventions; in the reduction of drug related harm. Addiction, 101 (10), 1384-1393.
30. Rhodes, T., Mikhailova, L., Sarang, A., Lowndes, C, Rylkov, A., Khutorskoy, M., et al. (2003). Situational factors influencing drug injecting, risk reduction and syringe exchange in Togliatti City, Russian Federation: A qualitative study of micro risk environment. Social Science and Medicine, 57 (1), 39-54.
31. Rhodes, T., Singer, M., Bourgois, P., Friedman, S., & Strathdee, S. (2005). The social structural production of HIV risk among injecting drug users. Social Science and Medicine, 61 (5), 1026-1044.
32. Shannon, K., Rusch, M., Shoveller, J., Alexson, D., Gison, K., & Tyndall, M. (2008). Mapping violence and policing as an environmental-structural barrier to health service and syringe availability among substance-using women in street-level sex work. International Journal of Drug Policy, 19 (2), 140-147.
33. Sobeyko, J., Duklas, T., Parczewski, M., Leszczyszyn-Pynka, M., Bejnarowicz, P., & Lazzarini, Z. (2007, May 13-17). After the rapid policy and response process: Drug policy change in Szczecin, Poland. Paper presented at the 18th International Harm Reduction Conference, Warsaw, Poland.
34. Sullivan, L., Metzger, D., Fudala, P., & Fiellin, D. (2005). Decreasing international HIV transmission: The role of expanding access to opioid agonist therapies for injection drug users. Addiction, 100 (2), 150-158.
35. Sullivan, S., & Wu, Z. (2007). Rapid scale up of harm reduction in China. International Journal of Drug Policy, 18 (2), 118-128.
36. Tashima, N., Crain, C, O'Reilly, K., & Elifson, C. (1996). The Community Identification (CID) process: A discovery model. Quantitative Health Research, 6 (1), 23-48.
37. Tempalski, B., Flom, P., Friednman, S., DesJarlais, D., Friedman, J., McKnight, C, et al. (2007). Social and political factors predicting the presence of syringe exchange programs in 96 US metropolitan areas. American Journal of Public Health, 97 (3), 437-447.
38. Thompson, D. (2005). The 'People's War' against drug and HIV/AIDS. China Brief 5 (14), 6-7.
39. Tkatchenko-Schmidt, E., Renton, A., Gevorgyna, R., Kavydenko, L., & Atun, R. (2008). Prevention of HIV/AIDS among injecting drug users in Russia: Opportunities and barriers to scaling-up of harm reduction programmes. Health Policy, 85 (2), 162-171.
40. UNTG, U. N. E. T. G. (2007a). HIV/AIDS China's titanic peril. Retrieved March 10, 2009, http://www.gateway2 china.com/report/AIDSchina2001update.pdf
41. UNTG, U. N. E. T. G. (2007b). Resource: A joint assessment of HIV/AIDS prevention and care in China. Retrieved March 10, 2009, http://aidsportal.org/ Article-Details.aspx?ID=3678
42. Vyshemirskaya, I., Osipenko, V., Burkhanova, O., Lazzarini, Z., Burris, S., & Chintalova-Dallas, R. (2008, May 11-15). Initiating practical health interventions for IDUs in Kaliningrad, Russia: Results of a rapid policy assessment and response (RPAR). Paper presented at the 19th International Harm Reduction Conference, Barcelona, Spain.
43. Wood, E., Kerr, T., Tyndall, M., Zhang, R., Hogg, R., Strathdee, S., et al. (2007). Rates of HIV/AIDS care and antiretroviral therapy response among active injection drug user. Addiction, 102 (9), 1503-1505.
44. Yang, L., Li, J., Zhang, Y., Li, H., Zhang, W., & Dai, F. Q. (2008). Societal perception and support for methadone maintenance treatment in a Chinese province with high HIV prevalence. The American Journal of Drug and Alcohol Abuse, 34 (1), 5-16.
45. Zheng, X., Zhang, J., & Qu, S. (1997). A cohort study of HIV infection among intraveneous drug users in Ruili and other two counties in Yunnan Province, China, 1992-1995. Chinese Journal of Epidemiology, 18 (5), 259-262.